Pomerantz Law Firm Announces the Filing of a Class Action

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Pomerantz Law Firm Announces the Filing of a Class Action against AECOM and Certain Officers – ACM

NEW YORK, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against AECOM (“AECOM” or the “Company”) (NYSE: ACM ) and certain of its officers.   The class action, filed in United States District Court, Central District of California, and docketed under 16-cv-06605,  is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired AECOM securities between February 11, 2015 and August 15, 2016 both dates inclusive (the “Class Period”).  This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”). 

If you are a shareholder who purchased AECOM securities during the Class Period, you have until October 31, 2016 to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased. 

[Click here to join this class action]

AECOM together with its subsidiaries, engages in designing, building, financing, and operating infrastructure assets worldwide.  The Company operates through three segments: Design and Consulting Services (DCS), Construction Services (CS), and Management Services (MS).  The DCS segment provides planning, consulting, architectural and engineering design, program management, and construction management services for industrial, commercial, institutional, and government clients, such as transportation, facilities, environmental, and energy/power markets.  The CS segment offers building construction and energy, as well as infrastructure and industrial construction services.  The MS segment provides program and facilities management and maintenance, training, logistics, consulting, technical assistance, and systems integration and information technology services primarily for agencies of the U.S. government and other national governments.

On October 17, 2014, AECOM announced that the Company had finalized its acquisition of URS Corp. (“URS” and the “URS Acquisition”).

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) AECOM engaged in fraudulent and deceptive business practices (ii) AECOM lacked effective internal controls over financial reporting; (iii) AECOM overstated the benefits of the URS Acquisition; (iv) AECOM overstated the Company’s free cash flow per share; and (v) as a result of the foregoing, AECOM’s public statements were materially false and misleading at all relevant times.

On August 16, 2016, Spruce Point Capital Management published a report on AECOM (the “Spruce Point Report”), stating that “after a careful forensic financial and accounting analysis of AECOM’s recent financial results and condition, we believe that AECOM’s stock is worth approximately 33% - 45% less than its current price.”  Among other issues, the Spruce Point Report cited AECOM management’s “misaligned incentive structure,” pursuant to which the Company’s “CEO’s $18 million compensation in 2015 [was] heavily tied to its aggressive interpretation of its Free Cash Flow per share,” and asserted that the Company had misrepresented the costs and benefits of the URS Acquisition.

On this news, AECOM stock fell $1.65, or 4.7%, to close at $33.44 on August 16, 2016, damaging investors. 

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Doximity Lawsuit: Investors Face November Deadline

Updated Category News Views 1

Hard Knocks for Doximity Investors Alright, so this isn't the place I usually find myself at that hour, but we're living in wild times if you're clinging to Doximity (NYSE:DOCS) shares. Listen up, because those lawyers are chiming in and they ain't just whistling Dixie. If you bought into DOCS between August 2024 and May 2026 and watched your investment bleed red ink,...

Continue Reading
Teleste Unveils AI-Enhanced Rail Info Platform Innovation

Updated Category News Views 8

A Shake-Up in Rail Passenger Information Now, here's something from left field that might just have people paying attention while on the go. Teleste, a Finnish company, just put out a gem in rail passenger information systems with the introduction of Acapela's AI-based voice tech into their S-ARRIVE platform. Picture clearer, more natural announcements for every stop,...

Continue Reading
Equity Alerts: Unraveling the Latest M&A Surprises

Updated Category News Views 5

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

Continue Reading
ICAC's Landmark Program Strengthens Africa's Anti-Corruption Efforts

Updated Category News Views 9

A Bold Step Towards Integrity Corruption has long been a thorn in the side of progress for many regions, and watching the Hong Kong International Academy Against Corruption (HKIAAC) step up to the plate in Africa feels like a much-needed move. I mean, when you've got the collective wisdom of folks who've been through the wringer on these issues, you'd be wise to pay heed....

Continue Reading
Cognizant Buys DyFlex for SAP, AI Edge in ANZ

Updated Category News Views 0

Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...

Continue Reading
MOOV Emerges as a Strong AI Contender in Canada

Updated Category News Views 2

A New Pioneer in AI Business Transformation Who would’ve thought two companies merging into one could shake things up this much? Introducing MOOV—a fresh sprout in the Canadian AI scene that's setting out to redefine how businesses across North America get stuff done. By blending the robust AI chops of Moov AI with the strategic design finesse of Nurun, this firm’s...

Continue Reading
Compounded Meds: A Tailored Approach to Health Needs

Updated Category News Views 1

Custom Compounding: A Lifeline for Specific Needs Standard meds can sometimes feel like a one-size-fits-all shirt—sure it fits, but not comfortably for everyone. Enter the world of custom-compounded medications, where pharmacists like Laura Temple in Azle, Texas, create tailor-made solutions for patients. Think of it as fine-tuning the exact gear needed to climb that...

Continue Reading
WuXi Biologics Clinches Top ESG Honors in Award Circuit

Updated Category News Views 5

Pounding the ESG Pavement Every now and then, a story pops up that makes you wonder if the finance folks are finally waking up to what's been slap-you-in-the-face obvious: sustainability ain't just a fancy word for do-gooders anymore. It's the real ticket to the future, and WuXi Biologics (2269.HK) just snagged the top-honor Jade Award at The Asset Corporate...

Continue Reading
Advancing Mental Health in NICU Families: 2026 Event Insight

Updated Category News Views 6

Addressing Critical Needs: Hand to Hold's Mission Now, I don't know about you, but when I hear "NICU," my mind goes straight to the intense pressure and emotional rollercoaster that it signifies for families. Hand to Hold, a nonprofit that’s knee-deep in supporting NICU families, isn’t just sitting on their hands. They're hosting a 2026 National NICU Mental Health...

Continue Reading
Highlight's Pulse Offers Real-Time Consumer Insights

Updated Category News Views 4

Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Invalda INVL's Share Voting Rights and Dynamics

Updated Category News Views 142

Understanding Voting Rights of Invalda INVL Shares Invalda INVL has made significant strides in managing its treasury shares and the voting rights associated with its issued shares. In recent transactions, they transferred 41,678 treasury shares to exercise stock options granted to selected employees. This step reflects the company's ongoing commitment to incentivize...

Continue Reading
TKO Group Holdings Sees Surge in Short Interest: Key Insights

Updated Category News Views 165

Overview of TKO Group Holdings Short Interest TKO Group Holdings has recently reported a notable increase in short interest. The company’s short percent of float has experienced a significant rise, now at 20.06%, which indicates a growing number of investors are betting against the stock. Currently, there are approximately 6.52 million shares sold short, accounting for...

Continue Reading
TG Therapeutics Completes ENHANCE Trial Enrollment for BRIUMVI

Updated Category News Views 247

Enrollment Completed in the Phase 3 ENHANCE Trial TG Therapeutics, Inc. (NASDAQ: TGTX) recently announced a significant milestone with the completion of patient enrollment in the randomized segment of the Phase 3 ENHANCE trial. This groundbreaking trial is set to examine a newly streamlined dosing schedule for IV BRIUMVI (ublituximab-xiiy), an innovative treatment for...

Continue Reading
Baja California Sur's EMBRACE IT: Pioneering Sustainable Tourism

Updated Category News Views 391

Setting the Stage for Sustainable Tourism Baja California Sur is embarking on an exciting new initiative called EMBRACE IT, aimed specifically at enhancing the region's sustainable tourism efforts. The state government is rolling out this forward-thinking tax initiative designed to bolster environmental conservation, foster community development, and improve local tourism...

Continue Reading
Halal Food Ingredients Market Growth Forecast to 2034

Updated Category News Views 56

Growth of the Halal Food Ingredients Market Allied Market Research has released important insights into the halal food ingredients market, revealing that it was valued at $58.4 billion last year. Forecasts indicate that this market is expected to grow to $108.9 billion by 2034, with a compound annual growth rate (CAGR) of 6.0% throughout the decade. This growth is...

Continue Reading